Explore more publications!
Africa Daily Journal
Got News to Share?

Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on March 5, 2026

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
Mar. 5, 2026

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Entrée Resources Announces Fiscal Year 2025 Results and Reviews Q4 Corporate Highlights
Mar. 5, 2026

Entrée Resources Announces Fiscal Year 2025 Results and Reviews Q4 Corporate Highlights

Indeterminate GlobeNewswire
Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors
Mar. 5, 2026

Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors

Indeterminate GlobeNewswire
CervoMed to Participate in Upcoming Investor Conferences
Mar. 5, 2026

CervoMed to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar. 5, 2026

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
North American Niobium to Commence Systematic Bottom-of-Till and Bedrock Sampling at Sabot Project, Quebec
Mar. 5, 2026

North American Niobium to Commence Systematic Bottom-of-Till and Bedrock Sampling at Sabot Project, Quebec

Indeterminate GlobeNewswire
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
Mar. 5, 2026

Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

Indeterminate GlobeNewswire
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
Mar. 5, 2026

Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

Indeterminate GlobeNewswire
BitMEX Launches the Equinox Race Campaign Featuring a 100,000 USDT Prize Pool
Mar. 5, 2026

BitMEX Launches the Equinox Race Campaign Featuring a 100,000 USDT Prize Pool

Indeterminate GlobeNewswire
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
Mar. 5, 2026

Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire
HPQ Silicon Finalizes Increased Ownership in Novacium SAS
Mar. 5, 2026

HPQ Silicon Finalizes Increased Ownership in Novacium SAS

Indeterminate GlobeNewswire
HPQ Silicium finalise son augmentation dans le capital Novacium SAS
Mar. 5, 2026

HPQ Silicium finalise son augmentation dans le capital Novacium SAS

Indeterminate GlobeNewswire
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
Mar. 5, 2026

Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates

Indeterminate GlobeNewswire
Copper Quest Completes AI-Driven Analysis at Kitimat & Identifies Large Concealed Conductive Target
Mar. 5, 2026

Copper Quest Completes AI-Driven Analysis at Kitimat & Identifies Large Concealed Conductive Target

Indeterminate GlobeNewswire
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
Mar. 5, 2026

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Indeterminate GlobeNewswire
ITM Announces Phase 3 COMPETE Trial Post-Hoc Subgroup Analyses with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Pancreatic Neuroendocrine Tumors at ENETS 2026 Conference
Mar. 5, 2026

ITM Announces Phase 3 COMPETE Trial Post-Hoc Subgroup Analyses with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Pancreatic Neuroendocrine Tumors at ENETS 2026 Conference

Indeterminate GlobeNewswire
HUTCHMED Reports 2025 Full Year Results and Business Updates
Mar. 5, 2026

HUTCHMED Reports 2025 Full Year Results and Business Updates

Indeterminate GlobeNewswire
Priavoid to Present Initial Phase 2 Safety Data for Alzheimer‘s and Preclinical PoC for Parkinson‘s Programs at AD/PD™ 2026
Mar. 5, 2026

Priavoid to Present Initial Phase 2 Safety Data for Alzheimer‘s and Preclinical PoC for Parkinson‘s Programs at AD/PD™ 2026

Indeterminate GlobeNewswire
Oculis to Participate in Upcoming Investor Conferences
Mar. 5, 2026

Oculis to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
Mar. 5, 2026

Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions